Media Newsroom of

Blue Horizon International

330 East 38th Street, 57 J New York, NY 10016
New York City, New York - 10016 United States
Phone: 917-602-0942
Website: http://www.BlueHorizonStemCells.com

Blue Horizon International is a healthcare consulting company with a unique concept that combines treatment, research and philanthropic efforts.

Blue Horizon International provides quality care and service for medical treatments globally, advanced technologies in stem cell therapies, and also provides resources needed to assist children and adults who are medically underserved. For more information please visit Blue Horizon International at www.bluehorizoninternational.com.

We associate with leading stem cell research scientists at the Biochemistry Institute of Wuhan University, The Stem Cell Centre, Hongqiao Brain Hospital and the prestigious Blue Horizon International Hospital Network.

The company is licensed by the Slovakian Ministry of Health to treat patients at Medissimo Hospital in Bratislava.  We are the only treatment provider approved by Wuhan University Department of Medicine.

Blue Horizon Stem Cells is the division of Blue Horizon International that conducts clinical research and provides regenerative stem cell therapies. To date, we have safely treated over 500 patients with more than 2250 regenerative procedures.  Patient medical outcomes are documented throughout the complete treatment cycle.

November 2013 the company introduced Special Skin Serum, which is the first offering of a breakthrough, proprietary skin care range that retains active stem cell properties.  Blue Horizon Stem Cell Skin Care does not contain actual stem cells, yet is derived from human stem cells used to treat patients in our research clinics

Blue Horizon International team to attend Clinical Trials Masterclass in New York

Brian Mehling, M.D. and Marina Manvelyan, Ph.D., will attend a three-day long Masterclass in Clinical Trials and Medicine Development from February 22 - 24, 2017 in New York, NY.The Masterclass in Clinical Trials is designed to provide insight into new…

Brian Mehling, M.D., US orthopedic trauma surgeon, stem cell researcher, founder of Blue Horizon International to attend World Economic Forum in Davos

Brian Mehling, M.D., world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, and founder of Blue Horizon International (BHI), will be attending the 47th Annual World Economic Forum (WEF) in Davos from January 17-20, 2017. This will be Dr. Mehling's fifth…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login